Metyrapone Oral Capsule

Brand(s)
Metopirone
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Laboratoire Hra Pharma (2014-08-06)
Oldest Current Product
2014-08-14
License(s)
NDA
RxNORM
ORAL CAPSULE\METYRAPONE
FDAOB
ORAL\CAPSULE\METYRAPONE
ORAL\TABLET\METYRAPONE
SPL Active
ORAL\CAPSULE, GELATIN COATED\METYRAPONE
SPL Moiety
ORAL\CAPSULE, GELATIN COATED\METYRAPONE

product(s) by strength(s)

metyrapone 250 mg oral capsule

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1763360455MetopironeNDALaboratoire Hra Pharma2014-08-14METYRAPONEORALCAPSULE, GELATIN COATEDNDA0129113a27d0ef-83a7-4e1c-9430-46a3326ee8d8

application(s)

#idtitleapplicantapproved drug
1NDA012911METOPIRONEHRA PHARMA LLCNDA012911_001, NDA012911_002

application drug(s)

#idcategory/deprecatedingredient strength(s)routedose formrldapprovedapplication
1NDA012911_001discontinuedMETYRAPONE (250MG)ORALTABLETFalseMETOPIRONE
2NDA012911_002RXMETYRAPONE (250MG)ORALCAPSULETrue1996-08-09METOPIRONE

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
13a27d0ef-83a7-4e1c-9430-46a3326ee8d8 (view SPL)Metopirone (metyrapone USP) CapsulesprescriptionHuman PrescriptionLaboratoire Hra Pharmamanufacture, relabel2014-08-061763360455

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII